GlassScriptPhysician profile
Ahmed Alabbady
NPI 1790030153
$30,743.93
in general payments reported to CMS, 2019-2025
25 companies · $4,084 in 2025
The $4,084 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.01 · 2020: $40.83 · 2021: $23K · 2022: $62.23 · 2023: $1,345 · 2024: $2,398 · 2025: $4,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,251 · Travel and Lodging: $1,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,250.62 |
| Travel and Lodging | $1,577.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22,837.94 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $2,808.22 | 2021-2025 | Triclip, Navitor, Amplatzer Amulet |
| Abiomed | $1,485.28 | 2023-2025 | Impella |
| Boston Scientific Corporation | $942.80 | 2021-2025 | Watchman Access System, Watchman Flx, Farapulse |
| Edwards Lifesciences Corporation | $357.43 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $351.58 | 2023-2025 | Lifevest |
| Shockwave Medical, INC | $294.92 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Amgen INC. | $254.86 | 2024-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $237.68 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $221.22 | 2024-2025 | Amvuttra, Onpattro |
| Astrazeneca Pharmaceuticals LP | $196.08 | 2019-2024 | Farxiga |
| Pfizer INC. | $172.46 | 2024-2025 | |
| Bridgebio Pharma, INC. | $122.83 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $78.01 | 2023-2025 | Camzyos, Eliquis |
| Lantheus Medical Imaging, INC. | $70.97 | 2023-2024 | Definity |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $61.31 | 2023 | Gore Cardioform Septal Occluder |
| Atricure, INC. | $53.25 | 2024 | |
| Esperion Therapeutics, INC. | $33.30 | 2025 | Nexletol |
| Angiodynamics, INC. | $32.17 | 2025 | Angiovac |
| Scpharmaceuticals INC. | $27.58 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.11 | 2024 | Jardiance |
| Asahi Intecc USA, INC. | $22.57 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $21.78 | 2024 | |
| Terumo Medical Corporation | $19.57 | 2023 | Glidesheath Slender, Metacross Otw |
| Merck Sharp & Dohme LLC | $14.01 | 2025 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Alabbady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.